Login
 Forum
 
 
Personal data sheet
 Print preview
VALIDITY EXPIRED
personal data approved: 2021. IV. 20.
Personal data
Piroska Szabóné Dr. Révész
name Piroska Szabóné Dr. Révész
name of institution
doctoral school
SzTE Doctoral School of Pharmaceutical Sciences (Core member emeritus)
the share of work in the different doctoral schools. SzTE Doctoral School of Pharmaceutical Sciences 100%
accreditation statement submitted to: University of Szeged
Contact details
E-mail address ReveszPiroskaszte.hu
phone number +36 62 545-572
own web page
Academic title
scientific degree, title Ph.D.
year degree was obtained 1992
discipline to which degree belongs pharmaceutics
institution granting the degree HAS
scientific degree, title DSc
year degree was obtained 2006
discipline to which degree belongs
institution granting the degree HAS
Employment
2019 - University of Szeged
other (not specified) (egyetemi tanár (professor emerita))
1975 - University of Szeged
university professor or researcher
Thesis topic supervisor
number of doctoral students supervised until now 16
number of students who fulfilled course requirements 16
students who obtained their degrees:
Csaba Bartos PhD 2020  DSPS-SzTE
(50%) Anita Chvatal PhD 2019  DSPS-SzTE
Gábor Katona PhD 2017  DSPS-SzTE
(50%) Alexandra Bocsik PhD 2016  DSPS-SzTE
(50%) Csilla Balla-Bartos PhD 2016  DSPS-SzTE
Csaba Mártha PhD 2015  DSPS-SzTE
(50%) Anita Pomázi PhD 2014  DSPS-SzTE
(50%) Lóránd Kiss PhD 2014  DSPS-SzTE
(50%) Levente László Kürti PhD 2012  DSPS-SzTE
Orsolya Jójártné Laczkovich PhD 2012  DSPS-SzTE
Angéla Szűts PhD 2009  DSPS-SzTE
Ágota Gombás PhD 2008  DSPS-SzTE
Bashiri Shahroodi Amir PhD 2008  DSPS-SzTE
Anikó Szepes PhD 2007  DSPS-SzTE
Reisi Nassab Parya PhD 2007  DSPS-SzTE
Edina Pallagi PhD 2005  DSPS-SzTE
Hajnalka Göcző PhD 2002  DSPS-SzTE
Fahim Serwanis Serwanis PhD 2000  DSPS-SzTE

  Thesis topic proposals
Research
research area Amorphization, micronization and nanonization of pharmacons with the aim of better bioavailability. Research and development of pulmonary and intranasal drug delivery systems.
research field in which current research is conducted pharmaceutics
Publications
2020

Katona Gábor, Tibor Balogh György, Dargó Gergő, Gáspár Róbert, Márki Árpád, Ducza Eszter, Sztojkov-Ivanov Anita, Tömösi Ferenc, Kecskeméti Gábor, Janáky Tamás, Kiss Tamás, Ambrus Rita, Pallagi Edina, Szabó-Révész Piroska, Csóka Ildikó: Development of Meloxicam-Human Serum Albumin Nanoparticles for Nose-to-Brain Delivery via Application of a Quality by Design Approach, PHARMACEUTICS 12: (2) 97
type of document: Journal paper/Article
number of independent citations: 3
language: English
URL 
2018

Bartos C, Ambrus R, Kovács A, Gáspár R, Sztojkov-Ivanov A, Márki Á, Janáky T, Tömösi F, Kecskeméti G, Szabó-Révész P: Investigation of Absorption Routes of Meloxicam and Its Salt Form from Intranasal Delivery Systems, MOLECULES 23: (4) 784
type of document: Journal paper/Article
language: English
URL 
2018

Bartos C, Jojart-Laczkovich O, Katona G, Budai-Szucs M, Ambrus R, Bocsik A, Grof I, Deli MA, Szabo-Revesz P: Optimization of a combined wet milling process in order to produce poly(vinyl alcohol) stabilized nanosuspension, DRUG DESIGN DEVELOPMENT AND THERAPY 12: pp. 1567-1580.
type of document: Journal paper/Article
number of independent citations: 1
language: English
URL 
2018

Gieszinger P, Tomuta I, Casian T, Bartos Cs, Szabó-Révész P, Ambrus R: Definition and validation of the Design Space for co-milled nasal powder containing nanosized lamotrigine, DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY 44: (10) pp. 1622-1630.
type of document: Journal paper/Article
language: English
URL 
2016

Horváth T, Bartos C, Bocsik A, Kiss L, Veszelka S, Deli MA, Újhelyi G, Szabó-Révész P, Ambrus R: Cytotoxicity of different excipients on RPMI 2650 human nasal epithelial cells, MOLECULES 21: (5) 658
type of document: Journal paper/Article
number of independent citations: 8
language: English
URL 
2016

Katona G, Szalontai B, Budai-Szűcs M, Csányi E, Szabó-Révész P, Jójárt-Laczkovich O: Formulation of paracetamol-containing pastilles with in situ coating technology, EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES 95: pp. 54-61.
type of document: Journal paper/Article
language: English
URL 
2012

Szuts A, Szabo-Revesz P: Sucrose esters as natural surfactants in drug delivery systems—A mini-review, INTERNATIONAL JOURNAL OF PHARMACEUTICS 433: (1-2) pp. 1-9.
type of document: Journal paper/Review paper
number of independent citations: 88
language: English
URL 
2011

Kürti L, Kukovecz Á, Kozma G, Ambrus R, Deli MA, Szabó-Révész P: Study of the parameters influencing the co-grinding process for the production of meloxicam nanoparticles, POWDER TECHNOLOGY 212: (1) pp. 210-217.
type of document: Journal paper/Article
number of independent citations: 25
language: English
URL 
2009

Ambrus R, Kocbek P, Kristl J, Sibanc R, Rajko R, Szabo-Revesz P: Investigation of preparation parameters to improve the dissolution of poorly water-soluble meloxicam, INTERNATIONAL JOURNAL OF PHARMACEUTICS 381: (2) pp. 153-159.
type of document: Journal paper/Article
number of independent citations: 63
language: English
URL 
2003

Gombás Á, Antal I, Szabó-Révész P, Marton S, Erõs I: Quantitative determination of crystallinity of alpha-lactose monohydrate by Near Infrared Spectroscopy (NIRS), INTERNATIONAL JOURNAL OF PHARMACEUTICS 256: (1-2) pp. 25-32.
type of document: Journal paper/Article
number of independent citations: 67
language: English
URL 
Number of independent citations to these publications:255 
Scientometric data
list of publications and citations
number of scientific publications that meet accreditation criteria:
602
number of scientific publications:
581
monographs and professional books:
3
monographs/books in which chapters/sections were contributed:
2 
scientific publications published abroad that meet the accreditation criteria:
356
publications not in Hungarian, published in Hungary, meeting the accreditation criteria:
81
number of independent citations to scientific publications and creative works:
3288
further relevant information regarding accreditation (in Hungarian)
Oponent in PhD and habilitation, as well as in doctoral procedures of the Hungarian Academy of Sciences, expert in the evaluation of domestic and foreign projects. Reviewer of journals and a member of the editorial board of Pharmaceutics (MDPI, Q1). Professional public task: scientific vice-president of Hungarian Society for Pharmaceutical Sciences (2016-2021), member of the Doctoral Accreditation College of the HAC (2019-) and the Habilitation Committee of the Semmelweis University (2019-).


2024. IV. 17.
ODT ülés
Az ODT következő ülésére 2024. június 14-én, pénteken 10.00 órakor kerül sor a Semmelweis Egyetem Szenátusi termében (Bp. Üllői út 26. I. emelet).

 
All rights reserved © 2007, Hungarian Doctoral Council. Doctoral Council registration number at commissioner for data protection: 02003/0001. Program version: 2.2358 ( 2017. X. 31. )